POT1 and glioma: Furthermore, as for some reported clinical associations, e.g., glioma, variants in other telomere length-associated loci represented a possible risk factor (also in haplotype blocks) [15], or the telomere length may not have been the only parameter to be evaluated to establish the biological impact of a POT1 variant, e.g., effect on specific gene pathways [49].